Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment
Heather Greenlee(Columbia University Irving Medical Center), Debu Tripathy(The University of Texas MD Anderson Cancer Center)
Cited by 762
Related Papers
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
|New England Journal of Medicine|2019|1k
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
|The Lancet Oncology|2018|1k
Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline Update
|Journal of Clinical Oncology|2024|210
Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer
|Breast Cancer Research and Treatment|2016|124
Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors
|Breast Cancer Research and Treatment|2013|117